The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy
Clin Transl Sci
.
2016 Dec;9(6):283-292.
doi: 10.1111/cts.12429.
Epub 2016 Nov 15.
Authors
C A Cummings
1
,
E Peters
1
,
L Lacroix
2
,
F Andre
3
,
M R Lackner
1
Affiliations
1
Oncology Biomarker Development, Genentech, Inc, South San Francisco, California, USA.
2
Department of Biology and Pathology, Translational Research Unit, Gustave Roussy Cancer Center, Villejuif, France.
3
Department of Medical Oncology, Université Paris Sud, Gustave Roussy Cancer Center, INSERM U981, Villejuif, France.
PMID:
27860319
PMCID:
PMC5351002
DOI:
10.1111/cts.12429
No abstract available
MeSH terms
High-Throughput Nucleotide Sequencing*
Humans
Medical Oncology*
Neoplasms / therapy
Precision Medicine*